Open AccessAnalgesic Effects of Vilazodone, Indatraline, and Talsupram in a Rat Model of Neuropathic Pain
Author(s) -
Levent Hacisüleyman,
Bülent Saraç,
Zıad Joha
Publication year - 2022
Publication title -
turkish journal of pharmaceutical sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.241
H-Index - 14
eISSN - 2148-6247
pISSN - 1304-530X
DOI - 10.4274/tjps.galenos.2021.41514
Subject(s) - neuropathic pain , pharmacology , gabapentin , tail flick test , antidepressant , reuptake inhibitor , analgesic , pregabalin , serotonin reuptake inhibitor , dopamine , medicine , monoamine neurotransmitter , serotonin , anesthesia , nociception , receptor , alternative medicine , pathology , hippocampus
Drugs that inhibit the reuptake of serotonin, norepinephrine, and/or dopamine are widely used for treating depressive disorders and have emerged as effective drugs for neuropathic pain. They have no substantial anti-nociceptive effects but are considered, with gabapentin/pregabalin, first-line drugs for neuropathic pain.